Dr. Loke and his colleagues declared no conflicts of interest in their meta-analysis. Dr. Montori and Dr. Shaw reported having no competing interests. Dr. Kaul also disclosed none related to his conclusions.
News
Cardiac Risk Higher With Rosiglitazone Than Pioglitazone
